1. Home
  2. BEEM vs NCEL Comparison

BEEM vs NCEL Comparison

Compare BEEM & NCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beam Global

BEEM

Beam Global

N/A

Current Price

$0.69

Market Cap

20.2M

Sector

Technology

ML Signal

N/A

Logo NewcelX Ltd. Ordinary Shares

NCEL

NewcelX Ltd. Ordinary Shares

N/A

Current Price

$2.76

Market Cap

19.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BEEM
NCEL
Founded
2006
2008
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.2M
19.4M
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
BEEM
NCEL
Price
$0.69
$2.76
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $2.50
N/A
AVG Volume (30 Days)
★ 593.3K
14.3K
Earning Date
11-24-2026
09-18-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 40.77
N/A
EPS
N/A
★ N/A
Revenue
★ $28,236,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$56.23
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.68
$1.83
52 Week High
$2.31
$5.12

Technical Indicators

Market Signals
Indicator
BEEM
NCEL
Relative Strength Index (RSI) 22.46 52.91
Support Level N/A $2.64
Resistance Level $1.66 $3.30
Average True Range (ATR) 0.05 0.28
MACD -0.01 0.04
Stochastic Oscillator 8.30 72.97

Price Performance

Historical Comparison
BEEM
NCEL

About BEEM Beam Global

Beam Global is a clean-technology innovation company. It develop, design, engineer, manufacture, and sell high-quality, renewably energized infrastructure products for electric vehicle ( EV ) charging, infrastructure for Smart Cities (the interconnected physical and digital elements within a city that utilize technology to enhance efficiency, sustainability, and quality of life for residents), energy security and disaster preparedness and energy-dense battery solutions in safe, compact and form-factors. Additionally, the company manufactures structures with electronic integration such as streetlighting, cell towers and energy infrastructure products as well as power electronics including invertors, charge controllers, power supplies and LED lighting.

About NCEL NewcelX Ltd. Ordinary Shares

NewcelX Ltd is a clinical-stage biopharmaceutical company focused on developing transformative therapies. Built on a validated human pluripotent stem cell (hPSC) platform, the Company's main program, NCEL-101, is designed to restore functional insulin production through scalable, off-the-shelf cell replacement. It is advancing a comprehensive therapeutic approach for Type 1 Diabetes, integrating cell therapy, immune protection, and translational science, including a phase IIa clinical trial for the treatment of Amyotrophic Lateral Sclerosis (ALS) in the field of regenerative medicine, as well as the development of treatments for Central Nervous System (CNS) disorders, including Narcolepsy, utilizing its Doxa platform. Its products are Holistic, IsletRx, AstroRx, and the DOXA platform.

Share on Social Networks: